Last update 21 Aug 2026

Organon Pharma (UK) Ltd.

Subsidiary Company|1953|United Kingdom|
www.msd-uk.co.uk

Overview

Tags

Infectious Diseases
Cardiovascular Diseases
Urogenital Diseases
Small molecule drug
Peptide Hormone
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases2
Neoplasms1
Immune System Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug2
Peptide Hormone1
Monoclonal antibody1
Top 5 TargetCount
RSV F protein(Respiratory syncytial virus F protein)1
CMV DNA terminase1
FSHR(Follicle-stimulating hormone receptor)1
Kv1.5 x VGSCs x hERG1

Related

4
Drugs associated with Organon Pharma (UK) Ltd.
Clesrovimab
Target
RSV F protein
Mechanism
Respiratory syncytial virus F protein inhibitors
Active Org.
Merck Sharp & Dohme Corp.Merck Sharp & Dohme Corp. [+6]
Originator Org.
Merck Sharp & Dohme Corp.Merck Sharp & Dohme Corp.
Active Indication
Lower Respiratory Tract Infections [+1]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date09 Jun 2025
Letermovir
Target
CMV DNA terminase
Mechanism
CMV DNA terminase inhibitors
Active Org.
Merck Canada, Inc.Merck Canada, Inc. [+7]
Originator Org.
AiCuris GmbH & Co. KGAiCuris GmbH & Co. KG
Active Indication
Graft Rejection [+5]
Inactive Indication
B-Cell Prolymphocytic Leukemia [+6]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Canada
First Approval Date01 Nov 2017
Vernakalant Hydrochloride
Target
Kv1.5 x VGSCs x hERG
Mechanism
Kv1.5 blockers [+2]
Active Org.
Advanz Pharma Corp. Ltd.Advanz Pharma Corp. Ltd. [+7]
Originator Org.
Correvio Pharma Corp.Correvio Pharma Corp.
Active Indication
Atrial Fibrillation [+1]
Inactive Indication
Atrial arrhythmia [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
European Union [+3]
First Approval Date01 Sep 2010
5
Clinical Trials associated with Organon Pharma (UK) Ltd.
CTR20191870
/ CompletedPhase 1
一项评价MK-7625A在中国健康受试者中的药代动力学、安全性和耐受性的单剂量和多剂量研究
[Translation] A single-dose and multiple-dose study to evaluate the pharmacokinetics, safety, and tolerability of MK-7625A in healthy Chinese subjects
CTR20190393
/ CompletedPhase 1
一项评价MK-0653C在健康中国受试者中单次给药和多次给药的药代动力学研究
[Translation] A single-dose and multiple-dose pharmacokinetic study to evaluate MK-0653C in healthy Chinese subjects
CTR20170435
/ CompletedPhase 3
MK-7625A联合甲硝唑与美罗培南相比治疗复杂性腹腔感染的III期、多中心、双盲、随机、活性药物对照的临床研究
[Translation] A phase III, multicenter, double-blind, randomized, active-controlled clinical study of MK-7625A combined with metronidazole versus meropenem in the treatment of complicated intra-abdominal infections
100 Clinical Results associated with Organon Pharma (UK) Ltd.
Login to view more data
0 Patents (Medical) associated with Organon Pharma (UK) Ltd.
Login to view more data
100 Deals associated with Organon Pharma (UK) Ltd.
Login to view more data
100 Translational Medicine associated with Organon Pharma (UK) Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Aug 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
1
3
Approved
Other
10
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free